Literature DB >> 27925095

Peritoneal dialysis: family care for chronic kidney disease patients in home-based treatment.

Joyce Martins Arimatea Branco Tavares1, Marcia Tereza Luz Lisboa2, Márcia de Assunção Ferreira2, Glaucia Valente Valadares2, Frances Valéria Costa E Silva1.   

Abstract

OBJECTIVE: : to propose a family care model for patients with chronic kidney disease in peritoneal dialysis based on evidence indicated by family members.
METHOD: : this was a qualitative descriptive study that used the Convergent Care Research method. It was conducted at a state hospital in Rio de Janeiro, including techniques for recording individual interviews and consisted of a group of 19 study participants. Data were analyzed according to the stages proposed by the method, generating a category that used a cultural question as the basis for patient care resulting in a proposal for home-based family care.
RESULTS: : the patient care model proposed includes dialogue and reflection in sharing the knowledge of "professional" and "popular" systems, aiming to improve the patient's quality of life.
CONCLUSION: : family members were able to promote care based on cultural preservation, accommodation and repatterning, as proposed by Leininger's Sunrise Model.

Entities:  

Mesh:

Year:  2016        PMID: 27925095     DOI: 10.1590/0034-7167-2016-0262

Source DB:  PubMed          Journal:  Rev Bras Enferm        ISSN: 0034-7167


  2 in total

1.  Efficacy of Omaha system-based nursing management on nutritional status in patients undergoing peritoneal dialysis: A randomized controlled trial protocol.

Authors:  Liqing Peng; Yuanyuan Gao; Rong Lu; Ruixiang Zhou
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

2.  Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies.

Authors:  Javier Roberti; Amanda Cummings; Michelle Myall; Jonathan Harvey; Kate Lippiett; Katherine Hunt; Federico Cicora; Juan Pedro Alonso; Carl R May
Journal:  BMJ Open       Date:  2018-09-04       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.